Company Presentation • 13 Mar 2023 20:00
Company Presentation • 23 May 2023 19:00
Company Presentation • 06 Sep 2023 19:00
Company Presentation • 14 Nov 2023 20:00
Company Presentation • 12 Dec 2023 23:30
ENTITY
Ligand Pharmaceuticals (LGND US)
Ligand Pharmaceuticals (LGND US)
6
Analysis
Health Care • United States
Ligand Pharmaceuticals Incorporated develops drugs which regulate hormone activated intracellular receptors. These receptors play a role in regulating the genetic processes affecting diseases such as gynecological disorders, certain cancers, as well as cardiovascular, inflammatory, and skin diseases.
more
x